ROQ — Roquefort Therapeutics Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- £2.60m
- £2.60m
- £0.00m
REG - Official List - Official List Notice
AnnouncementREG - Stock Exch Notice - Admission to Trading - 14/11/2024
AnnouncementREG - Roquefort Theraptcs. - Conversion of Convertible Loan Notes
AnnouncementRCS - Roquefort Theraptcs. - STAT-6 siRNA Presentation
AnnouncementREG - Roquefort Theraptcs. - Interim Results to 30 June 2024
AnnouncementREG - Roquefort Theraptcs. - Grant of Japan MK Cell Patent
AnnouncementREG - Roquefort Theraptcs. - STAT-6 siRNA Demonstrates Efficacy in Immunology
AnnouncementREG - Roquefort Theraptcs. - Grant of MK Cell Patent & Licencing Update
AnnouncementREG - Roquefort Theraptcs. - Results of AGM
AnnouncementREG - Roquefort Theraptcs. - Appointment of Broker
AnnouncementREG - Roquefort Theraptcs. - Notice of Annual General Meeting
AnnouncementREG - Roquefort Theraptcs. - Issue of Convertible Loan Notes & Board Changes
AnnouncementREG - Roquefort Theraptcs. - Midkine Antibody Licencing Deal
AnnouncementREG - Roquefort Theraptcs. - Annual Report & Financial Statements - 31 Dec 2023
AnnouncementREG - Roquefort Theraptcs. - Response to Share Price Movement
AnnouncementREG - Roquefort Theraptcs. - Positive Results: Midkine mRNA and STAT-6 siRNA
AnnouncementREG - Roquefort Theraptcs. - Operations Update
AnnouncementREG - Roquefort Theraptcs. - Change of Auditor
AnnouncementREG - Roquefort Theraptcs. - Significant Mesodermal Killer Cell Milestone
Announcement